Zürcher Nachrichten - First Covid vaccine side-effect claims land in German courts

EUR -
AED 4.350475
AFN 77.000016
ALL 96.454975
AMD 452.047591
ANG 2.120545
AOA 1086.286213
ARS 1725.238026
AUD 1.710479
AWG 2.135258
AZN 2.007664
BAM 1.951672
BBD 2.40163
BDT 145.711773
BGN 1.989397
BHD 0.449557
BIF 3532.68688
BMD 1.184609
BND 1.510131
BOB 8.239571
BRL 6.269424
BSD 1.192242
BTN 109.499298
BWP 15.600223
BYN 3.39623
BYR 23218.339784
BZD 2.398137
CAD 1.618478
CDF 2683.139764
CHF 0.916298
CLF 0.026022
CLP 1027.494776
CNY 8.235107
CNH 8.235012
COP 4347.219511
CRC 590.460955
CUC 1.184609
CUP 31.392143
CVE 110.03271
CZK 24.351003
DJF 212.331747
DKK 7.467676
DOP 75.072465
DZD 154.147531
EGP 55.878723
ERN 17.769138
ETB 185.235695
FJD 2.611648
FKP 0.865278
GBP 0.866695
GEL 3.192536
GGP 0.865278
GHS 13.062424
GIP 0.865278
GMD 86.476639
GNF 10463.043965
GTQ 9.145731
GYD 249.464409
HKD 9.250553
HNL 31.472956
HRK 7.534477
HTG 156.052534
HUF 381.797757
IDR 19913.694806
ILS 3.686918
IMP 0.865278
INR 108.607225
IQD 1562.095668
IRR 49901.661585
ISK 145.008115
JEP 0.865278
JMD 186.857891
JOD 0.839889
JPY 183.519063
KES 153.939966
KGS 103.594234
KHR 4794.938126
KMF 491.612449
KPW 1066.148258
KRW 1730.03927
KWD 0.36358
KYD 0.99369
KZT 599.696388
LAK 25660.935532
LBP 106778.978995
LKR 368.751529
LRD 214.927175
LSL 18.932911
LTL 3.497842
LVL 0.716558
LYD 7.482204
MAD 10.81612
MDL 20.055745
MGA 5328.75048
MKD 61.509887
MMK 2488.068394
MNT 4224.768089
MOP 9.588717
MRU 47.577162
MUR 54.077512
MVR 18.314459
MWK 2067.635018
MXN 20.751444
MYR 4.669768
MZN 75.530403
NAD 18.932592
NGN 1654.756728
NIO 43.877925
NOK 11.494689
NPR 175.200353
NZD 1.973375
OMR 0.457075
PAB 1.192378
PEN 3.986667
PGK 5.10431
PHP 69.772884
PKR 333.562994
PLN 4.217072
PYG 7987.138359
QAR 4.347422
RON 5.089195
RSD 117.152186
RUB 90.544141
RWF 1739.763902
SAR 4.443236
SBD 9.538015
SCR 17.104588
SDG 712.542061
SEK 10.581202
SGD 1.50757
SHP 0.888764
SLE 28.815636
SLL 24840.661178
SOS 681.469978
SRD 45.074975
STD 24519.018157
STN 24.448799
SVC 10.432843
SYP 13101.273866
SZL 18.924811
THB 37.603637
TJS 11.131048
TMT 4.146132
TND 3.425967
TOP 2.852254
TRY 51.525118
TTD 8.095909
TWD 37.508269
TZS 3057.464743
UAH 51.10611
UGX 4263.000384
USD 1.184609
UYU 46.272704
UZS 14577.164634
VES 409.805368
VND 30762.5233
VUV 140.721447
WST 3.211216
XAF 654.588912
XAG 0.015713
XAU 0.000262
XCD 3.201465
XCG 2.148954
XDR 0.814081
XOF 654.575127
XPF 119.331742
YER 282.321978
ZAR 19.247058
ZMK 10662.910096
ZMW 23.400599
ZWL 381.44367
  • RBGPF

    1.3800

    83.78

    +1.65%

  • SCS

    0.0200

    16.14

    +0.12%

  • CMSD

    -0.0400

    24.05

    -0.17%

  • BCC

    0.5100

    80.81

    +0.63%

  • CMSC

    0.0500

    23.76

    +0.21%

  • RELX

    -0.3700

    35.8

    -1.03%

  • BTI

    0.4600

    60.68

    +0.76%

  • JRI

    0.1400

    13.08

    +1.07%

  • RYCEF

    -0.4300

    16

    -2.69%

  • RIO

    -4.1000

    91.03

    -4.5%

  • NGG

    0.2000

    85.27

    +0.23%

  • BCE

    0.3700

    25.86

    +1.43%

  • VOD

    -0.0600

    14.65

    -0.41%

  • GSK

    0.9400

    51.6

    +1.82%

  • BP

    -0.1600

    37.88

    -0.42%

  • AZN

    0.1800

    92.77

    +0.19%

First Covid vaccine side-effect claims land in German courts

First Covid vaccine side-effect claims land in German courts

Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.

Text size:

In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.

But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.

In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.

The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.

In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.

She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.

Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.

He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.

- 'Rocky and long road' -

BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.

Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.

With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.

But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.

Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.

Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.

He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.

- 'Not an isolated case' -

A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".

In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.

A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.

She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.

"I hate it when people tell me that I'm an isolated case," she said. "I'm not."

To address the question of causality, the courts would likely have to obtain expert advice.

Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.

More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.

BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.

"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.

Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.

"I hope that people with post-vaccination syndromes can be taken seriously," she said.

R.Schmid--NZN